Merck invests more than € 290 million in its biosafety testing capacity at Rockville, Maryland, USA. Responds to growing global demand for biosafety testing as essential requirement for drug development and commercialization Expansion creates more than 500 new jobs in Rockville, Maryland, USA Strategic investment in Life Science Services business, part of the company’s “Big 3” […]
HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of the Pioneer Antibody Discovery Platform, a new antibody discovery service specifically designed to develop best-in-class biologic candidates. The Pioneer Platform features a state-of-the-art phage display library engineered to include […]
CBRE Group (NYSE:CBRE) today announced it has acquired Full Spectrum Group, a leading provider of expert technical support services for high-end laboratory systems in the U.S., from private equity firm Pfingsten Partners, for a total consideration of $110 million. This acquisition gives CBRE a new and enhanced technical capability that complements its existing global Integrated […]
Third Platform Divestiture of 2022 Chicago, IL – Pfingsten announces the sale of Full Spectrum Group (“Full Spectrum”) to CBRE Group (NYSE:CBRE), the world’s largest commercial real estate service and investment firm based on 2021 revenue. Full Spectrum, headquartered in Laguna Hills, CA, is a provider of highly specialized maintenance and repair services for critical laboratory […]
$97 million investment enhances bioanalytical services, helping pharma and biotech customers accelerate drug development WILMINGTON, N.C.–(BUSINESS WIRE)– Thermo Fisher Scientific, the world leader in serving science, today expanded its clinical research operations with the opening of a state-of-the art bioanalytical lab in Richmond, Virginia. The new unit will support increasing demand across biopharma for consistent, […]
Merck has opened a commercial facility for its new Millipore® CTDMO Services offering at the company’s site in Martillac, France. DARMSTADT, GERMANY New 2,700-square-meter facility expands production capacity for monoclonal antibodies (mAbs) and other recombinant proteins Clients benefit from differentiated CTDMO services that simplify experience to improve speed to market End-to-end support through clinical […]
First-of-its-kind facility for company in China to meet local demand New lab marks completion of phase 1 of company’s new Biologics Testing Center Phase 2 to include expansion of cell line characterization and lot release testing services Burlington, Massachusetts – MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science […]
Genovis AB and evitria AG today signed a service agreement to offer evitria’s customers fast LC-MS characterization of recombinant antibodies using Genovis proprietary enzyme technologies. evitria AG is a world leading service With this new service agreement, Genovis expands into a new business area that combines the ease of use of the SmartEnzymesTM with the competence […]
New subsidiary at the center of the Asian life science growth markets Targeted strengthening of customer focus with high-tech laboratory for pipette calibration and extensive range of high-quality laboratory services Even faster and more reliable delivery thanks to new central warehouse Singapore/Hamburg – The globally active Eppendorf Group continues its growth track in Asia in […]
State-of-the-art laboratories significantly expand project capacity to meet increasing market demand for Organ-on-a-Chip research services Cambridge, UK: CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the opening of new laboratory facilities at Cambridge Science Park, dedicated to its contract research services. The Company’s laboratory space has been […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
